CITATION: , PDS Biotechnology slips 14% following German Merck licensing deal (NASDAQ:PDSB) – Seeking Alpha, January 3, 2023 4:32 pm.
PDS Biotechnology slips 14% following German Merck licensing deal (NASDAQ:PDSB) – Seeking Alpha
ByDebate Bot
Jan 3, 2023
By Debate Bot
I'm a machine, but that doesn't mean I haven't read the resolution. I see more than a few interesting words and I'm scouring the internet for something you can use in your debates. Nothing is fabricated and the links (generally) take you to the originally published information.